v3.25.4
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities    
Net loss from continuing operations $ (3,101,901) $ (1,370,585)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation expense 10,818 1,046
Gain on sale of subsidiary assets (1,548,998)
Stock-based compensation 1,850,160 733,748
Amortization of debt discounts 2,132 43,050
Amortization of right-of-use asset 30,826 17,569
Loss on debt extinguishment 32,347 956,494
Decrease (increase) in assets:    
Other current assets 262,464 (60,454)
Increase (decrease) in liabilities:    
Accounts payable 368,769 (30,321)
Accrued expenses 96,299 (136,224)
Accrued expenses – related parties 104,539 13,533
Lease liability (36,428) (11,309)
Net cash (used in) operating activities from continuing operations (379,975) (1,392,451)
Net cash provided by operating activities from discontinued operations 358,576
Net cash provided by (used in) operating activities (379,975) (1,033,875)
Cash flows from investing activities    
Purchase of fixed assets (32,966) (27,655)
Proceeds from sale of subsidiary net assets 2,173,439
Net cash (used) in investing activities from continuing operations (32,966) 2,145,784
Net cash (used) in investing activities from discontinued operations
Net cash (used) in investing activities (32,966) 2,145,784
Cash flows from financing activities    
Repayments of notes payable (595,965)
Proceeds from notes payable 197,240
Repayments on convertible notes (650,000)
Proceeds from convertible notes 193,000
Payments of deferred offering costs (106,743) (30,000)
Proceeds from sales of Series D Preferred shares 76,296
Proceeds from sales of Series C Preferred shares 100
Net cash provided by (used in) financing activities 359,893 (1,275,965)
Net cash used in financing activities from discontinued operations (15,784)
Net cash provided by (used in) financing activities 359,893 (1,291,749)
Net increase (decrease) in cash (53,048) (179,840)
Cash - beginning 91,166 271,006
Cash - ending 38,118 91,166
Supplemental disclosures:    
Interest paid 266,533
Income taxes paid
Non-cash investing and financing activities:    
Addition of accounts payable and accrued interest into note payable 116,556 30,965
Deferred offering costs accrued and unpaid 120,241
Amortization of deferred offering costs 1,131
Initial right-of-use asset valuation 74,575
Common stock issued for conversion of note payable $ 40,000